Montreal Heart Institute

Category

Independent Data Monitoring Committee Recommends Continuing COLCORONA Study Indicating Potential of Colchicine

Back in June, TrialSite introduced the COLCORONA study led by the Montreal Heart Institute—a Phase 3 randomized, double-blind, placebo-controlled multicenter trial evaluating the efficacy and safety of colchicine in adult patients diagnosed with COVID-19 infection;...

At-Home Decentralized COLCORONA Trial Investigates if Colchicine Keeps COVID-19 Symptoms from Progressing to Reduce Hospitalization & Death

There is presently no available, FDA-approved medicine that can be administered at a patient’s home that can prevent the negative progression of SARS-CoV-2 symptoms leading to hospitalization and potentially death. Can a widely available, generic drug used for gout...

Pin It on Pinterest